Massimo S Fiandaca

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc The use of convection-enhanced delivery with liposomal toxins in neurooncology
    Massimo S Fiandaca
    Molecular Therapeutics Laboratory, Department of Neurological Surgery, University of California San Francisco, 1855 Folsom Street, Mission Center Building, Rm 226, San Francisco, CA 94103, USA
    Toxins (Basel) 3:369-97. 2011
  2. pmc Human/nonhuman primate AC-PC ratio--considerations for translational brain measurements
    Massimo S Fiandaca
    Movement Disorders Laboratory, Department of Neurological Surgery, University of California San Francisco, 1855 Folsom Street, San Francisco, CA 94103, USA
    J Neurosci Methods 196:124-30. 2011
  3. ncbi Gene therapy for Parkinson's disease: from non-human primates to humans
    Massimo S Fiandaca
    University of California San Francisco, Neurosurgery Department, 1855 Folsom Street, Mission Center Building Room 226, San Francisco, CA 94103, USA
    Curr Opin Mol Ther 12:519-29. 2010
  4. pmc Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates
    Dali Yin
    Department of Neurosurgery, University of California San Francisco, 1855 Folsom Street, MCB 226, San Francisco, CA 94103, USA
    Neuroimage 54:S196-203. 2011
  5. doi Cannula placement for effective convection-enhanced delivery in the nonhuman primate thalamus and brainstem: implications for clinical delivery of therapeutics
    Dali Yin
    Department of Neurosurgery, University of California, San Francisco, California 94103, USA
    J Neurosurg 113:240-8. 2010
  6. doi Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease
    Francisco Valles
    Movement Disorder Research Program, Department of Neurological Surgery, University of California, San Francisco, San Francisco, California 94103, USA
    Neurosurgery 67:1377-85. 2010
  7. pmc Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease
    R Mark Richardson
    Department of Neurological Surgery, University of California San Francisco, San Francisco, California 94143 0112, USA
    Mol Ther 19:1048-57. 2011
  8. pmc Anatomic compression caused by high-volume convection-enhanced delivery to the brain
    Francisco Valles
    Movement Disorder Research Program, Department of Neurological Surgery, University of California, San Francisco, San Francisco, California 94103, USA
    Neurosurgery 65:579-85; discussion 585-6. 2009
  9. pmc Striatal volume differences between non-human and human primates
    Dali Yin
    Department of Neurosurgery, University of California San Francisco, 1855 Folsom Street, San Francisco, CA 94103, United States
    J Neurosci Methods 176:200-5. 2009
  10. pmc Real-time MR imaging of adeno-associated viral vector delivery to the primate brain
    Massimo S Fiandaca
    Department of Neurological Surgery, University of California San Francisco, 1855 Folsom Street, Room 226, San Francisco, CA 94103, USA
    Neuroimage 47:T27-35. 2009

Collaborators

Detail Information

Publications11

  1. pmc The use of convection-enhanced delivery with liposomal toxins in neurooncology
    Massimo S Fiandaca
    Molecular Therapeutics Laboratory, Department of Neurological Surgery, University of California San Francisco, 1855 Folsom Street, Mission Center Building, Rm 226, San Francisco, CA 94103, USA
    Toxins (Basel) 3:369-97. 2011
    ..How CED and liposomal technologies may influence future neurooncologic treatments are also considered...
  2. pmc Human/nonhuman primate AC-PC ratio--considerations for translational brain measurements
    Massimo S Fiandaca
    Movement Disorders Laboratory, Department of Neurological Surgery, University of California San Francisco, 1855 Folsom Street, San Francisco, CA 94103, USA
    J Neurosci Methods 196:124-30. 2011
    ....
  3. ncbi Gene therapy for Parkinson's disease: from non-human primates to humans
    Massimo S Fiandaca
    University of California San Francisco, Neurosurgery Department, 1855 Folsom Street, Mission Center Building Room 226, San Francisco, CA 94103, USA
    Curr Opin Mol Ther 12:519-29. 2010
    ..In this review, the pertinent scientific research related to the use of gene therapy for the treatment of PD is summarized, with a particular focus on the accomplishments and challenges during the past 2 years...
  4. pmc Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates
    Dali Yin
    Department of Neurosurgery, University of California San Francisco, 1855 Folsom Street, MCB 226, San Francisco, CA 94103, USA
    Neuroimage 54:S196-203. 2011
    ....
  5. doi Cannula placement for effective convection-enhanced delivery in the nonhuman primate thalamus and brainstem: implications for clinical delivery of therapeutics
    Dali Yin
    Department of Neurosurgery, University of California, San Francisco, California 94103, USA
    J Neurosurg 113:240-8. 2010
    ....
  6. doi Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease
    Francisco Valles
    Movement Disorder Research Program, Department of Neurological Surgery, University of California, San Francisco, San Francisco, California 94103, USA
    Neurosurgery 67:1377-85. 2010
    ....
  7. pmc Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease
    R Mark Richardson
    Department of Neurological Surgery, University of California San Francisco, San Francisco, California 94143 0112, USA
    Mol Ther 19:1048-57. 2011
    ..The results elucidate the necessary parameters for achieving widespread GDNF expression in the putamenal motor area and afferent substantia nigra of PD patients...
  8. pmc Anatomic compression caused by high-volume convection-enhanced delivery to the brain
    Francisco Valles
    Movement Disorder Research Program, Department of Neurological Surgery, University of California, San Francisco, San Francisco, California 94103, USA
    Neurosurgery 65:579-85; discussion 585-6. 2009
    ..This article reports our analysis of CED infusions into normal brains and those compromised by tumors and how monitoring the CED infusion with MRI may be helpful in preventing some complications...
  9. pmc Striatal volume differences between non-human and human primates
    Dali Yin
    Department of Neurosurgery, University of California San Francisco, 1855 Folsom Street, San Francisco, CA 94103, United States
    J Neurosci Methods 176:200-5. 2009
    ....
  10. pmc Real-time MR imaging of adeno-associated viral vector delivery to the primate brain
    Massimo S Fiandaca
    Department of Neurological Surgery, University of California San Francisco, 1855 Folsom Street, Room 226, San Francisco, CA 94103, USA
    Neuroimage 47:T27-35. 2009
    ..It seems likely that the difference in distribution may be due to differences in tissue specificity of the two serotypes...
  11. pmc Image-guided convection-enhanced delivery platform in the treatment of neurological diseases
    Massimo S Fiandaca
    Department of Neurological Surgery, University of California San Francisco, San Francisco, California 94103, USA
    Neurotherapeutics 5:123-7. 2008
    ..Furthermore, we believe that this image-guided CED platform can be used in other translational neuroscience efforts, with eventual clinical application beyond neuro-oncology and PD...